Human 1 AGP acyltransferase 4 (AGPAT4) activation kit by CRISPRa

CAT#: GA111248

AGPAT4 CRISPRa kit - CRISPR gene activation of human 1-acylglycerol-3-phosphate O-acyltransferase 4



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Anti-AGPAT4 Rabbit Polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


AGPAT4 (Myc-DDK-tagged)-Human 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (AGPAT4)
    • 10 ug

CNY 3,656.00
CNY 3,990.00


Rabbit Polyclonal Anti-AGPAT4 Antibody
    • 100 ul

CNY 5,250.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol AGPAT4
Locus ID 56895
Kit Components

GA111248G1, 1 AGP acyltransferase 4 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA111248G2, 1 AGP acyltransferase 4 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA111248G3, 1 AGP acyltransferase 4 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001012733, NM_001012734, NM_020133
Synonyms 1-AGPAT4; dJ473J16.2; LPAAT-delta; RP3-473J16.2
Summary This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. This integral membrane protein converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...